Last reviewed · How we verify
Vancomycin plus Gentamicin
Vancomycin plus Gentamicin is a marketed combination antibiotic developed by the Michael E. DeBakey VA Medical Center, with a key composition patent expiring in 2028. The combination leverages the synergistic effects of both antibiotics to address complex bacterial infections, providing a strong therapeutic option in the market. The primary risk is the patent expiration in 2028, which could lead to increased competition from generic alternatives.
At a glance
| Generic name | Vancomycin plus Gentamicin |
|---|---|
| Sponsor | Michael E. DeBakey VA Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial (PHASE4)
- Local Antibiotics for Breast Implants (PHASE3)
- Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial (PHASE4)
- Intramedullary Calcium Sulfate Antibiotic Depot (PHASE3)
- TAILORED Therapeutic Regime in Patients With Preterm Premature Rupture Of Membranes to Prolong Pregnancy, Improve Maternal and Neonatal Outcomes, and Reduce Antibiotic Burden (PHASE3)
- Using Antibiotics to Prevent Infections in Hemodialysis Patients During Catheter Placement (PHASE4)
- Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections (NA)
- Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vancomycin plus Gentamicin CI brief — competitive landscape report
- Vancomycin plus Gentamicin updates RSS · CI watch RSS
- Michael E. DeBakey VA Medical Center portfolio CI